Advicenne (FRA:3MM) ROE % Adjusted to Book Value: 0.00% (As of Dec. 2025)

Advicenne FRA:3MM -9.18% 28 ROE % Adjusted to Book Value is 0.00% as of Dec. 2025. GuruFocus rates FRA:3MM with a GF Score™ of 28/100 and a GF Value™ of €1.99 (Possible Value Trap). The stock has 4 warning signs investors should review.

Advicenne's ROE % for the quarter that ended in Dec. 2025 was 0.00%. Advicenne's PB Ratio for the quarter that ended in Dec. 2025 was N/A. Advicenne's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was N/A.

Advicenne ROE % Adjusted to Book Value Related Terms

Advicenne ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Advicenne's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advicenne ROE % Adjusted to Book Value Chart

Advicenne Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.60

0.00

Advicenne Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:3MM vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Advicenne's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advicenne ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advicenne's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Advicenne's ROE % Adjusted to Book Value falls into.

Save Embed

28GF Score

Advicenne SA FRA:3MM

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Advicenne ROE % Adjusted to Book Value Calculation

Advicenne's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Advicenne's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 0.00% mean?

Advicenne (FRA:3MM) has a ROE % Adjusted to Book Value of 0.00% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Advicenne and its competitors.

Is Advicenne's ROE % Adjusted to Book Value too high?

Advicenne's current ROE % Adjusted to Book Value is 0.00%. Overall, Advicenne has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Advicenne's ROE % Adjusted to Book Value compare to VRTX and REGN?

Advicenne's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Biotechnology company?

A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Advicenne and its competitors. Advicenne's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Advicenne stock overvalued right now?

Based on GuruFocus' analysis, Advicenne (FRA:3MM) is currently considered Possible Value Trap. The stock's GF Value™ is €1.99, compared to a current price of €1.00 — trading 49.8% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Advicenne's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Advicenne (FRA:3MM), the current ROE % Adjusted to Book Value is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advicenne (FRA:3MM) Overvalued in 2026?

Based on GuruFocus' analysis, Advicenne stock appears to be undervalued. The current stock price of €1.00 is trading 49.8% below its estimated GF Value™ of €1.99. GuruFocus considers Advicenne to be Possible Value Trap.

Key valuation signals for FRA:3MM:

ROE % Adjusted to Book Value: 0.00%
GF Value™: €1.99 vs. price of €1.00 (49.8% below fair value)
GF Score™: 28/100 with 4 warning signs

No single metric tells the full story. See the FRA:3MM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Advicenne Business Description

Industry Healthcare Biotechnology

Comparable Companies XPAR:ALNFL XPAR:POXEL XPAR:ALTAO XPAR:AELIS XPAR:ALTME XPAR:ALOPM XPAR:SIGHT XPAR:ALBPS XPAR:ALINT XPAR:ALGEN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ALDVI:France

Address 2, rue Briconnet, Nimes, FRA, F-30 000

Website http://www.advicenne.com

Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.

28GF Score

Get the complete analysis for FRA:3MM

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00

Price

€1.99

GF Value

View FRA:3MM Analysis

See ROE % Adjusted to Book Value data for all stocks →